ReadyCell is a biotechnological company focused on providing sophisticated, cell based in vitro tools and R&D services for the ADME-Tox and Cosmetic segment. Our expertise include the manufacturing of patented, innovative cell-based and ready-to-use kits for efficacy and safety testing of active molecules as an alternative to animal testing, on drug discovery.

ReadyCell developed a patented technology that allows the shipment of living plated cells at room temperature. Maintaining their full viability and cellular characteristics, and thus allowing to streamline drug discovery pipelines and reducing experimental costs.

ReadyCell current Services portfolio covers a wide spectrum of drug discovery applications for in vitro and in silico screening, including adsorption, metabolism and toxicity assays.

The original EU-India Innocenter project received funding from the European Union's Horizon 2020
Coordination and Support Action Program under Grant Agreement No. 101004815 and was created with love by: